Role of IL-10 in allergen-specific immunotherapy and normal response to allergens.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Microbes and infection

• Publication date

  2001-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1286-4579(01)01449-6PMID 11564436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3‐kinase binding

  2000cited by this paper
• IL‐10 directly acts on T cells by specifically altering the CD28 co‐stimulation pathway

  2000cited by this paper
• Allergen immunotherapy: does it work and, if so, how and for how long?

  2000cited by this paper
• Immunoglobulin E–independent Major Histocompatibility Complex–restricted T Cell Peptide Epitope–induced Late Asthmatic Reactions

  1999cited by this paper
• Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1.

  1999cited by this paper
• IL‐10‐induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy

  1999cited by this paper
• Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1

  1999cited by this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

  1998cited by this paper
• Molecular basis of T cell inactivation by CTLA-4.

  1998cited by this paper
• Effects of peptide therapy on ex vivo T-cell responses.

  1998cited by this paper
• Determinants and Mechanisms of Human Immune Responses to Bee Venom Phospholipase A2

  1998cited by this paper
• Role of interleukin 10 in specific immunotherapy.

  1998cited by this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997.

  1998cited by this paper
• Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

  1998cited by this paper
• Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants

  1998cited by this paper
• Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells.

  1997cited by this paper
• A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

  1997cited by this paper
• Identification and functional characterization of a second chain of the interleukin‐10 receptor complex

  1997cited by this paper
• Glucocorticoids inhibit human antigen‐specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro

  1997cited by this paper
• The intensity of T cell receptor engagement determines the cytokine pattern of human allergen‐specific T helper cells

  1997cited by this paper
• Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56(lck) and ZAP-70 tyrosine kinase activities.

  1997cited by this paper
• IL-10: a potential therapy for allergic inflammation?

  1997cited by this paper
• Insect venom immunotherapy induces interleukin‐10 production and a Th2‐to‐Th1 shift, and changes surface marker expression in venom‐allergic subjects

  1997cited by this paper
• Nasal immunotherapy in weed-induced allergic rhinitis.

  1997cited by this paper
• CD40 expression by human peripheral blood eosinophils.

  1996cited by this paper
• Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells.

  1996cited by this paper
• Modulation by IL-10 of antigen-induced IL-5 generation, and CD4+ T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity.

  1996cited by this paper
• Life‐threatening anaphylactic shock due to skin application of Chlorhexidine

  1996cited by this paper
• Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils

  1996cited by this paper
• Treatment of cat allergy with T-cell reactive peptides.

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

  1996cited by this paper
• PI 3-kinase: a pivotal pathway in T-cell activation?

  1996cited by this paper
• p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation.

  1995cited by this paper
• Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.

  1995cited by this paper
• Functional regions of the mouse interleukin-10 receptor cytoplasmic domain

  1995cited by this paper
• IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes.

  1995cited by this paper
• Grass pollen immunotherapy: efficacy and safety during a 4‐year follow‐up study

  1995cited by this paper
• p56^ and p59^ regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor binding protein GRB-2 and T cell specific kinase ITK: implications for T cell co-stimulation.

  1995cited by this paper
• Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.

  1995cited by this paper
• High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells

  1994cited by this paper
• Induction of hapten-specific tolerance by interleukin 10 in vivo

  1994cited by this paper
• Maintenance of clonal anergy by endogenously produced IL-10.

  1994cited by this paper
• T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.

  1994cited by this paper
• PI 3‐kinase: structural and functional analysis of intersubunit interactions.

  1994cited by this paper
• B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10.

  1994cited by this paper
• Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils

  1994cited by this paper
• Lymphocyte responses and cytokines.

  1994cited by this paper
• IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells.

  1994cited by this paper
• Lymphokine production by human T cells in disease states.

  1994cited by this paper
• Position Paper: Immunotherapy with Hymenoptera venoms

  1993cited by this paper
• Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

  1993cited by this paper
• Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.

  1993cited by this paper
• Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family.

  1993cited by this paper
• Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I.

  1993cited by this paper
• Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

  1993cited by this paper
• T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2.

  1993cited by this paper
• IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.

  1992cited by this paper
• Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass.

  1992cited by this paper
• Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety.

  1992cited by this paper
• Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10.

  1992cited by this paper
• Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity.

  1992cited by this paper
• Bee venom phospholipase A2‐specific T cell clones from human allergic and non‐allergic individuals: cytokine patterns change in response to the antigen concentration

  1992cited by this paper
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

  1991cited by this paper
• T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma.

  1991cited by this paper
• IL-10 inhibits cytokine production by activated macrophages.

  1991cited by this paper
• Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.

  1991cited by this paper
• The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity.

  1990cited by this paper
• Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.

  1989cited by this paper
• Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

  1989cited by this paper
• The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.

  1988cited by this paper
• Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells

  1987cited by this paper
• Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.

  1986cited by this paper
• Isotypic and idiotypic characterization of anti-bee venom phospholipase A2 antibodies.

  1985cited by this paper
• Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.

  1985cited by this paper
• Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin

  1983cited by this paper

• Trichinella spiralis-derived extracellular vesicles induce regulatory T cells and reduce airway allergy in mice

  2025cites this paper
• Machine Learning-Empowered FTIR Spectroscopy Serum Analysis Stratifies Healthy, Allergic, and SIT-Treated Mice and Humans

  2020cites this paper
• B regulatory cells in allergy

  2020cites this paper
• Immune Effects of the Nitrated Food Allergen Beta-Lactoglobulin in an Experimental Food Allergy Model

  2019cites this paper
• Primary atopic disorders

  2018cites this paper
• Specific immunotherapy for allergic diseases

  2016cites this paper
• Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).

  2014cites this paper
• New Targets for Immune Modulation in Asthma

  2014cites this paper
• Pathophysiology of autoimmune pancreatitis.

  2014cites this paper
• Tolerogenic Dendritic Cells Derived from Donors with Natural Rubber Latex Allergy Modulate Allergen-Specific T-Cell Responses and IgE Production

  2014cites this paper
• by B Cells: Role of IL-10 T Regulatory-1 Cells Induce IgG4 Production

  2013cites this paper
• DGKα DNA vaccine relieves airway allergic inflammation in asthma model possibly via induction of T cell anergy.

  2013cites this paper
• Immunotherapy of Asthma: From Basic Research to Clinical Practices

  2012cites this paper
• A review of allergy and allergen specific immunotherapy.

  2011influential citation
• in infants and adults

  2010cites this paper
• Phenotype and function of CD25+ regulatory T cells in infants and adults

  2010cites this paper
• The concept of autoimmune pancreatitis and its immunological backgrounds

  2010cites this paper
• Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement

  2010cites this paper
• Schistosoma mansoni infection alters co-stimulatory molecule expression and cell activation in asthma.

  2009cites this paper
• Immunoglobulin G4: an odd antibody

  2009cites this paper
• Oral glucocorticoid treatment decreases interleukin‐10 receptor expression on peripheral blood leucocyte subsets

  2009cites this paper
• SYSTEM OF REGULATION OF THE ALLERGIC IMMUNE RESPONSE

  2008cites this paper
• Recent progress in allergen immunotherapy.

  2008cites this paper
• Development of an animal model for allergic conjunctivitis: influence of genetic factors and allergen concentration on immune response

  2008cites this paper
• Immunoreactivity profile of peripheral blood mononuclear cells from patients with ragweed‐induced allergic rhinitis

  2007cites this paper
• Use of multiple peptides containing T cell epitopes is a feasible approach for peptide‐based immunotherapy in Can f 1 allergy

  2007cites this paper
• Further studies on the immunopathogenesis of canine atopic dermatitis

  2007cites this paper
• Spezifische Immuntherapie bei der Behandlung der atopischen Dermatitis

  2007cites this paper
• Chapter 21 – Vaccination to Treat Noninfectious Diseases: Surveying the Opportunities

  2006cites this paper
• Immune stimulatory strategies for the prevention and treatment of asthma.

  2006cites this paper
• Allergic Contact Dermatitis and Atopic Eczema

  2006cites this paper
• DNA-based immunotherapy to treat atopic disease.

  2005cites this paper
• B Cells : Role of IL-10 T Regulatory-1 Cells Induce IgG 4 Production Hoerauf

  2005cites this paper
• EAACI POSITION PAPER PREVENTION AND TREATMENT OF HYMENOPTERA VENOM ALLERGY

  2005influential citation
• T Regulatory-1 Cells Induce IgG4 Production by B Cells: Role of IL-101

  2005cites this paper
• Peptide therapy for allergic diseases: basic mechanisms and new clinical approaches.

  2005cites this paper
• Antagonism between IL-4 and IL-10 in colitis and a helminth infection in Mus musculus

  2005cites this paper
• Development of an animal model for allergic conjunctivitis: Influence of genetic factors and allergen concentration on the immune response

  2005cites this paper
• CpG-Motive im Mausmodell für allergisches Asthma – Einfluß immunstimulatorischer DNA-Sequenzen auf die Entwicklung der allergischen Sensibilisierung und bronchialen Hyperreagibilität

  2005cites this paper
• Immunotherapy: 1999-2004.

  2004cites this paper
• Epithelial responses in airway inflammation and immunity

  2004cites this paper
• Immunologic influences on allergy and the TH1/TH2 balance.

  2004cites this paper
• Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria.

  2004cites this paper
• Molecular therapy versus standard treatment in allergy (Review).

  2004cites this paper
• Animal models of type I allergy using recombinant allergens.

  2004cites this paper
• Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation.

  2004cites this paper
• IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage.

  2004cites this paper
• Die Rolle von Zytokinen bei Allergien und Asthma

  2003cites this paper
• PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production.

  2003cites this paper
• Immunotherapy of allergic bronchopulmonary aspergillosis: a clinical and experimental approach.

  2003cites this paper
• Immunotherapy of allergic bronchopulmonary aspergillosis: a clinical and experimental approach.

  2003cites this paper
• New therapeutic strategies in allergic diseases.

  2003cites this paper
• Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity.

  2002cites this paper
• Allergic rhinitis is a local disease: the role of local IgE production, basophils and mast cells

  2002cites this paper
• Antibody-mediated specific immunotherapy of allergy

  2002cites this paper
• Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy?

  2002cites this paper
• Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis).

  2002cites this paper
• Antibodies Pollen Allergen , Bet v 1 , Induce Blocking Recombinant Fragments of the Major Birch T Cell Epitope-Containing Hypoallergenic

  2000cites this paper